Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eliem Therapeutics (ELYM)
NASDAQ:ELYM
RESEARCH TOOLSreports
Holding ELYM?
Track your performance easily
| Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 33.00K | - | - | - | - |
| Gross Profit | $ 33.00K | - | - | - | - |
| EBIT | $ -54.89M | $ -3.00M | $ -5.00M | $ -5.16M | $ -22.03M |
| EBITDA | $ -54.89M | $ -3.00M | $ -5.00M | $ -5.90M | $ -22.52M |
| Net Income Common Stockholders | $ -54.89M | $ -1.70M | $ -3.97M | $ -5.22M | $ -22.03M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 223.14M | $ 105.00M | $ 107.43M | $ 102.63M | $ 109.37M |
| Total Assets | $ 226.02M | $ 109.30M | $ 112.73M | $ 116.27M | $ 122.08M |
| Total Debt | $ 100.00K | $ 225.00K | $ 459.00K | $ 585.00K | $ 687.00K |
| Net Debt | $ -223.04M | $ -104.78M | $ -106.97M | $ -102.05M | $ -108.69M |
| Total Liabilities | $ 3.74M | $ 2.95M | $ 2.99M | $ 3.77M | $ 5.22M |
| Stockholders Equity | $ 222.28M | $ 106.36M | $ 109.74M | $ 112.47M | $ 116.81M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -5.31M | $ -1.82M | $ 3.49M | $ -7.96M | $ -15.18M |
| Operating Cash Flow | $ -667.00K | $ -1.82M | $ 3.49M | $ -7.96M | $ -15.18M |
| Investing Cash Flow | $ -9.64M | $ 13.75M | $ 28.04M | $ -1.60M | $ 5.80M |
| Financing Cash Flow | $ 128.40M | $ 15.00K | $ 528.00K | $ 24.00K | $ 1.00K |